Back to EGF+61 genetic polymorphisms and lung cancer risk: looking to the future! De volta aos polimorfismos genéticos do EGF+61 e risco de câncer do pulmão: olhando para o futuro!...

by Ramon Andrade De Mello
Published 2012-01-01

Metastatic melanoma and vemurafenib: novel approaches

by Ramon Andrade De Mello
Published 2012-04-01

Sacrum osteosarcoma after pelvic radiation for uterine cervical cancer: highlighted issues

by Ramon Andrade De Mello

Back to EGF+61 genetic polymorphisms and lung cancer risk: looking to the future!

by Ramon Andrade De Mello

Anaplastic lymphoma kinase gene rearrangement and non-small cell lung cancer management: a step forward in personalized therapy

by Ramon Andrade De Mello, António Araújo
Published 2013-05-01

Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices

by Ramon Andrade De Mello, António Araújo
Published 2012-11-01

Biomarkers for Non-Small Cell Lung Cancer: From the Bench to the Bedside

by Ramon Andrade de Mello, Giovanna Araújo Amaral
Published 2020-10-01

Stridor and respiratory failure due to tracheobronchomalacia: case report and review of the literature

by Ramon Andrade de Mello, Adriana Magalhães, Abílio José Vilas-Boas

Loci identified through genome-wide association studies and lung cancer risk: is there anything more?

by Ramon Andrade De Mello, António Araújo, Venceslau Hespanhol, Rui Manuel Reis

Loci identified through genome-wide association studies and lung cancer risk: is there anything more? Loci identificados através de estudo de associação genômic...

by Ramon Andrade De Mello, António Araújo, Venceslau Hespanhol, Rui Manuel Reis
Published 2013-04-01

Knee glomangioma: a rare location for a glomus tumor

by Ricardo Gonçalves, Ana Lopes, Clara Júlio, Carlos Durão, Ramon Andrade de Mello
Published 2014-12-01

Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.

by Ramon Andrade de Mello, Sandra Gerós, Marcos Pantarotto Alves, Filipa Moreira, Isabel Avezedo, José Dinis
Published 2014-01-01

New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives

by Ramon Andrade de Mello, Nathália Moisés Neves, Hakaru Tadokoro, Giovanna Araújo Amaral, Pedro Castelo-Branco, Victor André de Almeida Zia
Published 2020-11-01

The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer.

by Ramon Andrade de Mello, Mónica Ferreira, Filipa Soares-Pires, Sandra Costa, João Cunha, Pedro Oliveira, Venceslau Hespanhol, Rui Manuel Reis
Published 2013-01-01

Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer

by Guangsheng Zhu, Dian Ren, Xi Lei, Ruifeng Shi, Shuai Zhu, Ning Zhou, Lingling Zu, Ramon Andrade De Mello, Jun Chen, Song XU
Published 2021-03-01

The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer

by Ramon Andrade De Mello, Nathália Moisés Neves, Giovanna Araújo Amaral, Estela Gudin Lippo, Pedro Castelo-Branco, Daniel Humberto Pozza, Carla Chizuru Tajima, Georgios Antoniou
Published 2020-06-01

Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth

by Konstantinos Kamposioras, Davide Mauri, Konstantinos Papadimitriou, Alan Anthoney, Nadia Hindi, Nadia Hindi, Branka Petricevic, Mario Dambrosio, Antonis Valachis, Pantelis Kountourakis, Jindrich Kopecky, Cvetka Grašič Kuhar, Lazar Popovic, Nataliya P. Chilingirova, Nataliya P. Chilingirova, George Zarkavelis, Ramon Andrade de Mello, Ramon Andrade de Mello, Natalija Dedić Plavetić, Christos Christopoulos, Bianca Mostert, John R. Goffin, Dimitiros Tzachanis, Haytham Hamed Saraireh, Fei Ma, Ida Pavese, Maria Tolia
Published 2020-11-01